In summary, TIIA can reduce liver lipid accumulation, inflammatory infiltration, and fibrosis in NASH mice, and this effect may be achieved by activating the PPARα/FGF21 axis to negatively regulate the ER stress-induced UPR and inhibit NLRP3 inflammasome activation. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.